Part 1: Regulatory

In this episode, we sit down with a clinical research coordinator from a government-funded hospital to explore the unique challenges and regulatory differences between publicly funded and private pharmaceutical company-sponsored trials. We discuss key topics such as study selection, start-up timelines, and the distinct approval processes that shape the landscape of government-backed research. How do these differences impact trial efficiency, patient access, and innovation? Tune in for an insider’s perspective on the critical nuances of conducting research outside the private sector. Stay tuned for Part 2.